Literature DB >> 27161516

Adoptive T cell transfer: Imagining the next generation of cancer immunotherapies.

Luca Gattinoni1.   

Abstract

Entities:  

Keywords:  Adoptive T cell transfer; CAR engineered T cells; Cancer immunotherapy; MicroRNA therapeutics; Neoantigens; Stem cell-like T cells; T cell differentiation; T cell reprogramming; TCR engineered T cells; Tumor microenvironment

Mesh：

Year:  2016        PMID： 27161516      PMCID： PMC6377561          DOI： 10.1016/j.smim.2016.03.019

Source DB:  PubMed          Journal:  Semin Immunol        ISSN： 1044-5323            Impact factor:   11.130


× No keyword cloud information.
  17 in total

Review 1.  Adoptive immunotherapy for cancer: building on success.

Authors:  Luca Gattinoni; Daniel J Powell; Steven A Rosenberg; Nicholas P Restifo
Journal:  Nat Rev Immunol       Date:  2006-05       Impact factor: 53.106

Review 2.  Paths to stemness: building the ultimate antitumour T cell.

Authors:  Luca Gattinoni; Christopher A Klebanoff; Nicholas P Restifo
Journal:  Nat Rev Cancer       Date:  2012-09-21       Impact factor: 60.716

Review 3.  Accessories to the crime: functions of cells recruited to the tumor microenvironment.

Authors:  Douglas Hanahan; Lisa M Coussens
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

Review 4.  Immune checkpoint blockade: a common denominator approach to cancer therapy.

Authors:  Suzanne L Topalian; Charles G Drake; Drew M Pardoll
Journal:  Cancer Cell       Date:  2015-04-06       Impact factor: 31.743

5.  Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients.

Authors:  Lukas Baitsch; Petra Baumgaertner; Estelle Devêvre; Sunil K Raghav; Amandine Legat; Leticia Barba; Sébastien Wieckowski; Hanifa Bouzourene; Bart Deplancke; Pedro Romero; Nathalie Rufer; Daniel E Speiser
Journal:  J Clin Invest       Date:  2011-05-09       Impact factor: 14.808

Review 6.  Pervasive roles of microRNAs in cardiovascular biology.

Authors:  Eric M Small; Eric N Olson
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

7.  Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer.

Authors:  Eric Tran; Simon Turcotte; Alena Gros; Paul F Robbins; Yong-Chen Lu; Mark E Dudley; John R Wunderlich; Robert P Somerville; Katherine Hogan; Christian S Hinrichs; Maria R Parkhurst; James C Yang; Steven A Rosenberg
Journal:  Science       Date:  2014-05-09       Impact factor: 47.728

Review 8.  Adoptive immunotherapy for cancer or viruses.

Authors:  Marcela V Maus; Joseph A Fraietta; Bruce L Levine; Michael Kalos; Yangbing Zhao; Carl H June
Journal:  Annu Rev Immunol       Date:  2014-01-09       Impact factor: 28.527

9.  PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors.

Authors:  Alena Gros; Paul F Robbins; Xin Yao; Yong F Li; Simon Turcotte; Eric Tran; John R Wunderlich; Arnold Mixon; Shawn Farid; Mark E Dudley; Ken-Ichi Hanada; Jorge R Almeida; Sam Darko; Daniel C Douek; James C Yang; Steven A Rosenberg
Journal:  J Clin Invest       Date:  2014-03-25       Impact factor: 14.808

Review 10.  Reassessing target antigens for adoptive T-cell therapy.

Authors:  Christian S Hinrichs; Nicholas P Restifo
Journal:  Nat Biotechnol       Date:  2013-10-20       Impact factor: 54.908
View more
  2 in total

Review 1.  Innate Immune Cells and Their Contribution to T-Cell-Based Immunotherapy.

Authors:  Pierpaolo Ginefra; Girieca Lorusso; Nicola Vannini
Journal:  Int J Mol Sci       Date:  2020-06-22       Impact factor: 5.923

Review 2.  Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer.

Authors:  Andrew M K Law; Fatima Valdes-Mora; David Gallego-Ortega
Journal:  Cells       Date:  2020-02-27       Impact factor: 6.600
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.